Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

I am not invested in AUPH for any DES effect it might have.

Me neither, I invested here before I was even aware of the DES indication.
Glad that Vascepa solved your problems. I would imagine that
it might not work for other patients where Vocl. might be useful.

Aurinia management must have some notion of the usefulness
of the Vocl/DES formulation, even in the context of currently available
remedies. The fact that Restasis is still on the market is at the very
least a good hint that there's an ongoing need, AND there are indications
that Vocl. is better than Restasis.